CTAP TFA is a potent, highly selective, and BBB penetrant µ opioid receptor antagonist, with an IC50 of 3.5 nM. CTAP TFA displays over 1200-fold selectivity over delta opioid (IC50=4500 nM) and somatostatin receptors. CTAP TFA can be used for the study of L-DOPA-induced dyskinesia (LID) and opiate overdose or addiction[1][2].
Molecular Weight:
1104.30 (free base)
Purity:
99.60
Formula:
C51H69N13O11S2.xC2HF3O2
Target:
Opioid Receptor
Application Notes:
MCE Product type: Peptides
* VAT and and shipping costs not included. Errors and price changes excepted
